首页> 外文期刊>Proceedings of the National Academy of Sciences of the United States of America >A hypervariable N-terminal region of Yersinia LcrV determines Toll-like receptor 2-mediated IL-10 induction and mouse virulence
【24h】

A hypervariable N-terminal region of Yersinia LcrV determines Toll-like receptor 2-mediated IL-10 induction and mouse virulence

机译:耶尔森菌LcrV的N端高变区决定了Toll样受体2介导的IL-10诱导和小鼠毒性

获取原文
获取原文并翻译 | 示例
           

摘要

The virulence antigen LcrV of Yersinia enterocolitica O:8 induces IL-10 in macrophages via Toll-like receptor 2 (TLR2). The TLR2-active region of LcrV is localized within its N-terminal amino acids (aa) 31-57. Sequencing of codons 25-92 of the lcrV gene from 59 strains of the three pathogenic Yersinia species revealed a hypervariable hotspot within aa 40-61. According to these sequence differences, seven LcrV groups were identified, with Y. pestis and Y. pseudo-tuberculosis represented in group Ⅰ and the other six distributed within Y. enterocolitica. By testing LcrV sequence-derived synthetic oligopeptides of all seven LcrV groups in CD14/TLR2-transfected human embryonic kidney 293 cells, we found the highest TLR2 activity with a peptide derived from group IV comprising exclusively Y. enterocolitica O:8 strains. These findings were verified in murine peritoneal macrophages by using recombinant LcrV truncates representing aa 1-130 from different Yersinia spp. By systematically replacing charged aa residues by glutamine in synthetic oligopeptides, we show that the K42Q substitution leads to abrogation of TLR2 activity in both in vitro cell systems. This K42Q substitution was introduced in the lcrV gene from Y. enterocolitica O:8 WA-C(pYV), resulting in WA-C(pYVLcrV_(K42Q)), which turned out to be less virulent for C57BL/6 mice than the parental strain. This difference in virulence was not observed in TLR2~(-/-) or IL-10~(-/-) mice, proving that LcrV contributes to virulence by TLR2-mediated IL-10 induction. LcrV is a defined bacterial virulence factor shown to target the TLR system for evasion of the host's immune response.
机译:小肠结肠炎耶尔森菌O:8的毒力抗原LcrV通过Toll样受体2(TLR2)诱导巨噬细胞中的IL-10。 LcrV的TLR2活性区域位于其N末端氨基酸(aa)31-57内。来自三个致病耶尔森菌物种的59个菌株的lcrV基因密码子25-92的测序显示在40-61位氨基酸内有一个高变热点。根据这些序列差异,鉴定了七个LcrV组,其中鼠疫耶尔森氏菌和假结核耶尔森氏菌在Ⅰ组中代表,其余六个分布在小肠结肠炎耶尔森氏菌中。通过在CD14 / TLR2转染的人胚肾293细胞中测试所有七个LcrV组的LcrV序列衍生的合成寡肽,我们发现,用仅包含肠炎耶尔森菌O:8菌株的IV组衍生的肽,TLR2活性最高。通过使用代表来自不同耶尔森菌属的1-130号氨基酸的重组LcrV截短蛋白在鼠腹膜巨噬细胞中证实了这些发现。通过用合成的寡肽中的谷氨酰胺系统性地取代带电荷的aa残基,我们表明K42Q取代导致在两个体外细胞系统中TLR2活性的废止。这种K42Q取代被引入到来自小肠结肠炎耶尔森菌的lcrV基因中O:8 WA-C(pYV),导致产生WA-C(pYVLcrV_(K42Q)),事实证明它对C57BL / 6小鼠的毒性低于亲本应变。在TLR2〜(-/-)或IL-10〜(-/-)小鼠中未观察到这种毒力差异,证明LcrV通过TLR2介导的IL-10诱导导致了毒力。 LcrV是定义明确的细菌毒力因子,显示其可针对TLR系统逃避宿主的免疫反应。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号